Chinese biotech firm deploys AI chromosome testing to accelerate IVF procedures and tap rising fertility demand

Chinese biotechnology company Hangzhou Diagens Biotechnology is expanding the use of artificial intelligence driven chromosome testing to improve efficiency in in vitro fertilisation and strengthen its commercial growth strategy. The initiative comes as China faces declining birth rates and increasing demand for assisted